TRENDING :  Market Movers  |  Top 50   AMZN (-0.17%)    NVDA (1.32%)    SQ (-1.53%)    DGAZ (6.96%)    BABA (-2.21%)    FB (-1.71%)    NFLX (-1.95%)    PYPL (0.02%)    RDFN (-1.69%)    SFIX (1.51%)    SPY (-0.56%)    TLRY (2.23%)    GS (-0.34%)    GOOG (-1.04%)    GGAL (-2.12%)    FDX (-0.75%)    ETHUSD (%)    DIS (-0.74%)    AMD (1.03%)    AIONUSD (%)    BA (0.08%)    ASHS (-2.3%)    ARRY (-1.1%)    AOS (-1.44%)    CMG (-1.16%)

 ABBV - AbbVie Inc.

$90.13 (-2.32%)

Next Earnings

11/2/2018

BMO


OPEN RECOMMENDATIONS

No recommendations found.


This list is limited to recommendations made in last 7 days only. Subscribe to a service to see all their recommendations.

TRADERS TRACKING $ABBV

Service NameTrader% Success
OptionIncomerandom motion95.00 %Subscribe
Inactive~Inactive~82.00 %Follow
Alpha Swing TradesJonathan71.00 %Follow
Growth Safe BetsHao62.00 %Subscribe
MA MA MIAHao60.00 %Subscribe
Market FocusHao60.00 %Subscribe
Spectre Aggressive Growth AccountSpectre Trading60.00 %Follow
Freestyle Model Portfolio v01Swing Trader - Speculator - Fusion Analyst (Technicals, fundamentals, quantitative)56.00 %Follow
Modified Wheel StrategyBrian Terry50.00 %Follow
Biotech picksmr jackson50.00 %Follow
Kessel Growth and ValueKessel45.00 %Follow

TRENDING ARTICLES


AbbVie Announces Resolution Of HUMIRA Patent Disputes With Fresenius Kabi

NASDAQ NEWS   -  12:00 AM

Company News For Oct 15, 2018

NASDAQ NEWS   -  10/15/18

2 Pharmaceutical Stocks to Buy With Dividends of 3% or Better

NASDAQ NEWS   -  10/15/18

Pharma Stock Roundup: ABBV, NVS' Humira Biosimilar Agreement, BMY's New Cancer Deal

NASDAQ NEWS   -  10/12/18

AbbVie Settles With Novartis to Delay Humira Biosimilar in US

NASDAQ NEWS   -  10/12/18

Bristol-Myers Inks Deal and Invests $12 Million in Compugen

NASDAQ NEWS   -  10/12/18

3 Big Pharma Stocks Racing Along the Road to China

NASDAQ NEWS   -  10/12/18

Sandoz, AbbVie Announce Global Resolution Of Humira Patent Disputes

NASDAQ NEWS   -  10/11/18

AbbVie Inc. (ABBV) Ex-Dividend Date Scheduled for October 12, 2018

NASDAQ NEWS   -  10/11/18

AbbVie (ABBV) Stock Moves -1.54%: What You Should Know

NASDAQ NEWS   -  10/10/18

Neurocrine Inks Deal with Private Biotech to Make CNS Drugs

NASDAQ NEWS   -  10/10/18

J&J's Stelara Succeeds in Phase III Ulcerative Colitis Study

NASDAQ NEWS   -  10/10/18

Ex-Dividend Reminder: AbbVie, ConnectOne Bancorp and Pennymac Mortgage Investment Trust

NASDAQ NEWS   -  10/10/18

3 Top Biotech Stocks to Buy in October

NASDAQ NEWS   -  10/08/18

AbbVie's Orilissa Gets Canadian Nod to Treat Endometriosis

NASDAQ NEWS   -  10/08/18

Roche's Hemlibra Receives FDA Approval for Label Expansion

NASDAQ NEWS   -  10/05/18

Gilead Announces Positive Data From Ongoing Biktarvy Study

NASDAQ NEWS   -  10/05/18

Mylan To Launch Biosimilar To Humira In Europe - Quick Facts

NASDAQ NEWS   -  09/20/18

California Sues AbbVie Alleging Kickbacks For Humira

NASDAQ NEWS   -  09/19/18

Bristol-Myers: FDA To Review SBLA For Empliciti With Pomalidomide, Dexamethasone

NASDAQ NEWS   -  08/23/18

AbbVie Announces Positive Results From Phase 3 Extension Study On Elagolix

NASDAQ NEWS   -  08/22/18